The $199 Skeptic's Trial, One Month of Compounded Semaglutide
For new patients who want to evaluate compounded semaglutide before committing to the full 90-day protocol. One-time fee. One month of medication. Real physician oversight.
- Physician evaluation by Dr. Sharma
- Prescription if you're a candidate (medical history reviewed first)
- 1-month supply of compounded semaglutide from a state-licensed compounding pharmacy operating under section 503A
- Packaging and shipping are confirmed before fulfillment only if a prescription is approved and the dispensing pharmacy can fulfill it for the patient location
- No auto-renewal, no membership lock-in
Who this is for
The Skeptic's Trial is designed for adults who meet GLP-1 eligibility (BMI 30+ or BMI 27+ with a weight-related condition) and want a shorter introduction before committing to the 90-day program. Three patient profiles where it fits well:
- You've never tried GLP-1 therapy and want to know how your body tolerates it.
- You've heard about compounded medications and want to evaluate the quality of our 503A pharmacy partner before a longer commitment.
- You're comparing compounded options against branded Wegovy or Ozempic and want to see how compounded performs for you specifically.
What's included, in plain language
- Submit the qualifying quiz, 2 minutes online.
- Complete the medical intake form, your full medical history. Same form Dr. Sharma uses for the 90-day program.
- Physician evaluation, Dr. Sharma reviews your intake. If you're a candidate, the prescription is written and sent to a licensed 503A compounding pharmacy. If you're not a candidate, the medication portion of the fee is refunded.
- Pharmacy fulfillment is available only after a prescription is approved and a dispensing pharmacy confirms that it can lawfully serve the patient's location. The pharmacy confirms packaging, timing, and delivery details before fulfillment.
- Self-administered weekly subcutaneous injection, at home, with written instructions and access to your care team for questions.
What it doesn't include (be specific)
- Ongoing follow-up beyond the month. The trial is intentionally a one-month commitment.
- Dose escalation. The trial uses the starting dose only. Dose titration over 12-16 weeks is part of the 90-day program.
- B12 / lipotropic combinations. Available in the 90-day program.
- Auto-renewal. No subscription, no membership.
What happens after the month
After the first month, you may stop, continue with a 90-day program, or discuss another approach with the physician. There is no upgrade fee and no pressure to continue. The trial exists to help you make an informed decision.
The honest comparison: trial vs. 90-day program
Trial: $199 one-time / 1 month. Lower commitment. Starting dose only. No included follow-ups.
90-Day Essential Reset: $499 one-time / 3 months ($166/mo equivalent). Full dose titration. Monthly follow-ups. Better cost per month if you know GLP-1 is for you.
For most uninsured patients who have already decided GLP-1 is the path, the 90-day program is the better economic choice. For patients with hesitation or compounded-medication questions, the trial is the right entry point.
Frequently asked questions
What does the $199 Skeptic's Trial include?
The Skeptic's Trial is a one-time $199 program that includes a physician evaluation by Dr. Sharma, a prescription for compounded semaglutide if you're a candidate, and one month of compounded semaglutide from a state-licensed compounding pharmacy operating under section 503A. Packaging and shipping are confirmed before fulfillment only if a prescription is approved and the dispensing pharmacy can fulfill it for the patient location. No further commitment required after the month.
Who is the trial for?
Adults meeting GLP-1 eligibility (BMI 30+ or BMI 27+ with a weight-related condition) who want a shorter introduction before the full 90-day program. Especially useful if you've never tried GLP-1 or want to evaluate compounded medications first.
How is it different from the 90-day program?
The 90-day Essential Reset ($499 total, $166/month) offers longer dose titration and monthly follow-ups. The trial ($199, one month) is a shorter introduction. Afterward, you may stop, continue, or discuss another approach with the physician.
Can I do the trial via telemedicine?
Yes. The initial physician evaluation can be done via secure video visit anywhere in California. Medication fulfillment is available only if a prescription is approved and the dispensing pharmacy can fulfill it for the patient location, with packaging and shipping details confirmed by the pharmacy before fulfillment.
What if I'm not a candidate?
If Dr. Sharma's review determines you're not a candidate, the medication portion of the trial is not dispensed and the medication-related portion of the fee is refunded. The physician evaluation portion is non-refundable because the work was performed.
Is the trial available in Spanish?
Yes. Our bilingual patient care team supports the trial process in Spanish. Visit Nueva Figura at nuevafiguraahora.com for the Spanish-language version of the program.
Straight answers before you pay
- $119 covers the physician review and the prescription decision; medication is billed separately.
- Not a candidate? Medication is not dispensed and the medication portion of any trial fee is refunded. The evaluation fee is not refunded because the medical review was performed.
- No long-term contracts. HSA and FSA cards accepted, with Cherry, Klarna, and Affirm financing available.
This page is informational only and not medical advice. Eligibility for the Skeptic's Trial is determined during the medical consultation by Dr. Anjmun Sharma. Individual results vary. Compounded semaglutide is not an FDA-approved finished product. Any possible fulfillment requires separate verification of the dispensing pharmacy's identity, license, legal authority, and ability to serve the patient and location before fulfillment. Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. New Hope Weight Loss is not affiliated with, endorsed by, or sponsored by Novo Nordisk. Pricing current as of May 2026.